Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo

Journal of Neurochemistry

Volumn 73, Issue 6, 1999, Pages 2299-2309

  Yuan, Peixiong ^a   Chen, Guang ^a   Manji, Husseini K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AP 1; c Jun NH2 terminal kinases; Gene expression; Lithium; Manic depressive illness; Mitogen activated protein kinases; Protein kinase C

Indexed keywords

LITHIUM; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ARTICLE; DNA BINDING; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE;

ANIMALS; ANTIMANIC AGENTS; CELLS, CULTURED; DNA; ENZYME ACTIVATION; ENZYME INHIBITORS; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENES, JUN; GENES, REPORTER; HIPPOCAMPUS; HUMANS; INDOLES; INOSITOL; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LITHIUM CHLORIDE; MALE; MALEIMIDES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROBLASTOMA; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, WISTAR; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032705688     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0732299.x     Document Type: Article

References (97)

1. Andrews N. C. and Faller D. V. (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499-2503.
2. Asghari V., Wang J. F., Reiach J. S., and Young L. T. (1998) Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY-5Y cells. Mol. Brain Res. 58, 95-102.
3. Atkins C. M., Chen S.-J., Klann E., and Sweatt J. D. (1997) Increased phosphorylation of myelin basic protein during hippocampal long-term potentiation. J. Neurochem. 68, 1960-1967.
4. Bailey C. H., Kaang B. K., Chen M., Martin K. C., Lim C. S., Casadio A., and Kandel E. R. (1997) Mutation in the phosphorylation sites of MAP kinase blocks learning-related internalization of apCAM in Aplysia sensory neurons. Neuron 18, 913-924.
5. Berhow M. T., Hiroi N., and Nestler E. J. (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707-4715.
6. Blum S., Moore A. N., Adams F., and Dash P. K. (1999) A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J. Neurosci. 19, 3535-3544.
7. Bornancin F. and Parker P. J. (1997) Phosphorylation of protein kinase C-alpha on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J. Biol. Chem. 272, 3544-3549.
8. Bullock B. P., McNeil G. P., and Dobner P. R. (1994) Synergistic induction of neurotensin gene transcription in PC12 cells parallels changes in AP-1 activity. Brain Res. Mol. Brain Res. 27, 232-242.
9. Chaleka-Franaszek E. and Chuang D. M. (1998) Chronic lithium inhibits glutamate-induced activation of mitogen-activated protein kinase (MAPK) in cerebellar neurons. Soc. Neurosci. Abstr. 24, 997.
10. Chen G., Yuan P. X., Hawver D. B., Potter W. Z., and Manji H. K. (1997) Increase in AP-1 transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology 16, 238-245.
11. Chen G., Yuan P.-X., Jiang Y.-M., Huang L-D., and Manji H. K. (1998) Lithium increases tyrosine hydroxylase levels both in vivo and in vitro. J. Neurochem. 70, 1768-1771.
12. Chen G., Yuan P. X., Jiang Y., Huang L. D., and Manji H. K. (1999) Valproate enhances the expression of AP-1 transcription factor regulated genes. Mol. Brain Res. 64, 52-58.
13. Cobb M. H., Xu S., Cheng M., Ebert D., Robbins D., Goldsmith E., and Robinson M. (1996) Structural analysis of the MAP kinase ERK2 and studies of MAP kinase regulatory pathways. Adv. Pharmacol. 36, 49-65.
14. Crow T., Xue-Bian J.-J., Siddiqi V., Kang Y., and Neary J. T. (1998) Phosphorylation of mitogen-activated protein kinase by one-trial and multi-trial classical conditioning. J. Neurosci. 18, 3480-3487.
15. Derijard B., Raingeaud J., Barrett T., Wu I. H., Han J., Ulevitch R. J., and Davis R. J. (1995) Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267, 682-685.
16. Diamond D. A., Parsian A., Hunt C. R., Lofgren S., Spitz D. R., Goswami P. C., and Gius D. (1999) Redox factor-1 (Ref-1) mediates the activation of AP-1 in HeLa and NIH 3T3 cells in response to heat shock. J. Biol. Chem. 274, 16959-16964.
17. Divish M. M., Sheftel G., Boyle A., Kalasapudi V. D., Papolos D. F., and Lachman H. M. (1991) Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action. J. Neurosci. Res. 28, 40-48.
18. Drevets W. C., Price J. L., Simpson J. R. Jr., Todd R. D., Reich T., Vannier M., and Raichle M. E. (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827.
19. Duman R. S., Heninger G. R., and Nestler E. J. (1997) A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54, 597-606.
20. 42 mitogen-activated protein kinase in hippocampal long term potentiation. J. Biol. Chem. 271, 24329-24332.
21. English J. D. and Sweatt J. D. (1997) A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J. Biol. Chem. 272, 19103-19106.
22. Feinstein D. L. (1998) Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chloride. J. Neurochem. 71, 883-886.
23. Fukunaga K. and Miyamoto E. (1998) Role of MAP kinase in neurons. Mol. Neurobiol. 16, 79-95.
24. Garcia-Paramio P., Cabrerizo Y., Bornancin F., and Parker P. J. (1998) The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation. Biochem. J. 333, 631-636.
25. Goodwin F. K. and Jamison K. R. (1990) Manic-Depressive Illness. Oxford University Press, New York.
26. Greenberg M. L. and Lopes J. M. (1996) Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae. Microbiol. Rev. 60, 1-20.
27. Greene N. D. and Copp A. J. (1997) Inositol prevents folate-resistant neural tube defects in the mouse. Nat. Med. 3, 60-66.
28. Gupta S., Barrett T., Whitmarsh A. J., Cavanagh J., Sluss H. K., Derijard B., and Davis R. J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760-2770.
29. Gutkind J. S. (1998) The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273, 1839-1842.
30. Hedgepeth C. M., Conrad L. J., Zhang J., Huang H. C., Lee V. M. Y., and Klein P. S. (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185, 82-91.
31. 2-terminal protein kinases in tissues of heat-stressed mice. J. Biol. Chem. 272, 9113-9119.
32. Hughes P. and Dragunow M. (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47, 133-178.
33. Hyman S. E. and Nestler E. J. (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am. J. Psychiatry 153, 151-162.
34. Jope R. S. (1999a) A bimodal model of the mechanism of action of lithium. Mol. Psychiatry 4, 21-25.
35. Jope R. S. (1999b) Anti-bipolar therapy: mechanism of action of lithium, Mol. Psychiatry 4, 117-128.
36. Jope R. S. and Williams M. B. (1994) Lithium and brain signal transduction systems. Biochem. Pharmacol. 77, 429-441.
37. Jovanovic J. N., Benfenati F., Siow Y. L., Sihra T. S., Sanghera J. S., Pelech S. L., Greengard P., and Czernik A. J. (1996) Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc. Natl Acad. Sci. USA 93, 3679-3683.
38. Kalasapudi V. D., Sheftel G., Divish M. M., Papolos D. F., and Lachman H. M. (1990) Lithium augments fos protooncogene expression in PC12 pheochromocytoma cells: implications for therapeutic action of lithium. Brain Res. 521, 47-54.
39. Karin M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486.
40. Karin M. and Smeal T. (1992) Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem. Sci. 17, 418-422.
41. Kawakami Y., Hartman S. E., Holland P. M., Cooper J. A., and Kawakami T. (1998) Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7. J. Immunol. 161, 1795-1802.
42. Ketter T. A., George M. S., Kimbrell T. A., Willis M. W., Benson B. E., and Post R. M. (1997) Neuroanatomical models and brain imaging studies, in Bipolar Disorder: Biological Models and Their Clinical Application (Joffe R. T. and Young L. T., eds), pp. 179-217. Marcel Dekker, New York.
43. Klein P. S. and Melton D. A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455-8459.
44. Korner M., Rattner A., Mauxion F., Sen R., and Citri Y. (1989) A brain-specific transcription activator. Neuron 3, 563-572.
45. Kernhauser J. M. and Greenberg M. E. (1997) A kinase to remember: dual roles for MAP kinase in long-term memory. Neuron 18, 839-842.
46. Lee Y., Hamamura T., Ohashi K., Fujiwara Y., and Kuroda S. (1999) The effect of lithium on methamphetamine-induced regional Fos protein expression in the rat brain. Neuroreport 10, 895-900.
47. Leslie R. A., Moorman J. M., and Grahame-Smith D. G. (1993) Lithium enhances 5-HT2A receptor-mediated c-fos expression in rat cerebral cortex. Neuroreport 5, 241-244.
48. Li W. G., Zaheer A., Coppey I., and Oskarsson H. J. (1998) Activation of JNK in the remote myocardium after large myocardial infarction in rats. Biochem. Biophys. Res. Commun. 246, 816-820.
49. Li X. and Jope R. S. (1995) Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J. Neurochem. 65, 2500-2508.
50. Lin A., Smeal T., Binetruy B., Deng T., Chambard J. C., and Karin M. (1993) Control of AP-1 activity by signal transduction cascades. Adv. Second Messenger Phosphoprotein Res. 28, 255-260.
51. Luttrell L. M., van Biesen T., Hawes B. E., Koch W. J., Krueger K. M., Touhara K., and Lefkowitz R. J. (1997) G-protein-coupled receptors and their regulation: activation of the MAP kinase signaling pathway by G-protein-coupled receptors. Adv. Second Messenger Phosphoprotein Res. 31, 263-277.
52. Manji H. K. and Lenox R. H. (1994) Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 16, 11-28.
53. Manji H. K. and Lenox R. H. (1999) Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic depressive illness. Biol. Psychiatry (in press).
54. Manji H. K., Potter W. Z., and Lenox R. H. (1995) Signal transduction pathways. Molecular targets for lithium's actions. Arch. Gen. Psychiatry 52, 531-543.
55. Martin K. C., Michael D., Rose J. C., Barad M., Casadio A., Zhu H., and Kandel E. R. (1997) MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia. Neuron 18, 899-912.
56. Matsubara M., Kusubata M., Ishiguro K., Uchida T., Titani K., and Taniguchi H. (1996) Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J. Biol. Chem. 271, 21108-21113.
57. Miller J. C. and Mathe A. A. (1997) Basal and stimulated c-fos mRNA expression in the rat brain: effect of chronic dietary lithium. Neuropsychopharmacology 16, 408-418.
58. Minden A. and Karin M. (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta 1333, F85-F104.
59. Mitsui H., Maruyama T., Kimura S., and Takuwa Y. (1998) Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells. Hepatology 27, 1362-1367.
60. Moorman J. M. and Leslie R. A. (1998) Paradoxical effects of lithium on serotonergic receptor function: an immunocytochemical, behavioural and autoradiographic study. Neuropharmacology 37, 357-374.
61. Murphy T. H., Blatter L. A., Bhat R. V., Fiore R. S., Wier W. G., and Baraban J. M. (1994) Differential regulation of calcium/calmodulin-dependent protein kinase II and p42 MAP kinase activity by synaptic transmission. J. Neurosci. 14, 1320-1331.
62. 38 mitogen-activated protein kinase. J. Biol. Chem. 273, 22892-22898.
63. Nakshatri H. and Currie A. (1996) Differential whole-cell extract preparation and electrophoretic mobility shift assay to evaluate the effect of tyrosine phosphatases on DNA binding activity of transcription factors. Anal. Biochem. 236, 178-181.
64. Namima M., Sugihara K., and Okamoto K. (1998) Lithium inhibits the reverse tolerance and the c-Fos expression induced by methamphetamine in mice. Brain Res. 782, 83-90.
65. Namima M., Sugihara K., Watanabe Y., Sasa H., Umekage T., and Okamoto K. (1999) Quantitative analysis of the effects of lithium on the reverse tolerance and the c-Fos expression induced by methamphetamine in mice. Brain Res. Brain Res. Protoc. 4, 11-18.
66. Nestler E. J. (1998) Antidepressant treatments in the 21st century. Biol. Psychiatry 44, 526-533.
67. Newton T. R., Patel N. M., Bhat-Nakshatri P., Stauss C. R., Goulet R. J. Jr., and Nakshatri H. (1999) Negative regulation of transactivation function but not DNA binding of NF-kappaB and AP-1 by IkappaBbetal in breast cancer cells. J. Biol. Chem. 274, 18827-18835.
68. Ozaki N. and Chuang D.-M. (1997) Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J. Neurochem. 69, 2336-2344.
69. Pulverer B. J., Kyriakis J. M., Avruch J., Nikolakaki E., and Woodgett J. R. (1991) Phosphorylation of c-Jun mediated by MAP kinases. Nature 353, 670-674.
70. Qatsha K. A., Rudolph C., Marme D., Schachtele C., and May W. S. (1993) Go 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro. Proc. Natl. Acad. Sci. USA 90, 4674-4678.
71. Raingeaud J., Gupta S., Rogers J. S., Dickens M., Han J., Ulevitch R. J., and Davis R. J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-aclivated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426.
72. Rattner A., Korner M., Rosen H., Baeuerle P. A., and Citri Y. (1991) Nuclear factor κB activates proenkephalin transcription in T lymphocytes. Mol. Cell. Biol. 11, 1017-1022.
73. Roberson E. D., English J, D., Adams J. P., Selcher J. C., Kondratick C., and Sweatt J. D. (1999) The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J. Neurosci. 19, 4337-4348.
74. Robinson M. J. and Cobb M. H. (1997) Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9, 180-186.
75. Robinson M. J., Stippec S. A., Goldsmith E., White M. A., and Cobb M. H. (1998) A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8, 1141-1150.
76. Sakamoto M. K., Suzuki K., Takiya S., Yoshimura Y., Imai T., Matsumoto A., and Nakamura S. (1998) Developmental profiles of phosphorylated and unphosphorylated CREBs in murine calvarial MC3T3-E1 cells. J. Biochem. (Tokyo) 123, 399-407.
77. Schonwasser D. C., Marais R. M., Marshall C. J., and Parker P. J. (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18, 790-798.
78. Segal R. A. and Greenberg M. E. (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463-489.
79. Siow Y. L., Kalmar G. B., Sanghera J. S., Tai G., Oh S. S., and Pelech S. L. (1997) Identification of two essential phosphorylated threonine residues in the catalytic domain of Mekk1. Indirect activation by Pak3 and protein kinase C. J. Biol. Chem 272, 7586-7594.
80. Smeal T., Binetruy B., Mercola D., Grover B. A., Heldecker G., Rapp U. R., and Karin M. (1992) Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol. Cell. Biol. 12, 3507-3513.
81. Stariha R. L., Kikuchi S., Siow Y. L., Pelech S. L., Kim M., and Kim S. U. (1997) Role of extracellular signal-regulated protein kinases 1 and 2 in oligodendroglial process extension. J. Neurochem. 68, 945-953.
82. Suzuki T., Okumura-Noji K., and Nishida E. (1995) ERK2-type mitogen-activated protein kinase (MAPK) and its substrates in postsynaptic density fractions from the rat brain. Neurosci. Res. 22, 277-285.
83. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., and Loriolle P. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781.
84. 2-terminal kinase. Proc. Natl. Acad. Sci. USA 94, 7337-7342.
85. Unlap M. T. and Jope R. S. (1997) Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells. Neuropsychopharmacology 17, 12-17.
86. Wang J. F., Young L. T., Li P. P., and Warsh J. J. (1997) Signal transduction abnormalities in bipolar disorder, in Bipolar Disorder: Biological Models and Their Clinical Applications (Joffe R. T. and Young L. T., eds), pp. 41-79. Marcel Dekker, New York.
87. Weiner E. D., Kalasapudi V. D., Papolos D. F., and Lachman H. M. (1991) Lithium augments pilocarpine-induced fos gene expression in rat brain. Brain Res. 553, 117-122.
88. Werlen G., Jacinto E., Xia Y., and Karin M. (1998) Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 117, 3101-3111.
89. Whitmarsh A. J. and Davis R. J. (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74, 589-607.
90. Whitmarsh A. J., Shore P., Sharrocks A. D., and Davis R. J. (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science 269, 403-407.
91. Whitmarsh A. J., Cavanagh J., Tournier C., Yasuda J., and Davis R. J. (1998) A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281, 1671-1674.
92. Williams M. B. and Jope R. S. (1995) Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology (Berl.) 122, 363-368.
93. Xu S., Robbins D., Frost J., Dang A., Lange-Carter C., and Cobb M. H. (1995) MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 92, 6808-6812.
94. Xu X., Raber J., Yang D., Su B., and Mucke L. (1997) Dynamic regulation of c-Jun N-terminal kinase activity in mouse brain by environmental stimuli. Proc. Natl. Acad. Sci. USA 94, 12655-12660.
95. 38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gbetagamma and Galphaq/11 subunits. J. Biol. Chem. 272, 27771-27777.
96. Yuan P. X., Chen G., and Manji H. K. (1998) Lithium stimulates gene expression through the AP-1 transcription factor pathway. Mol. Brain Res. 58, 225-230.
97. Zigova T., Willing A. E., Tedesco E. M., Borlongan C. V., Saporta S., Snable G. L., and Sanberg P. R. (1999) Lithium chloride induces the expression of tyrosine hydroxylase in hNT neurons. Exp. Neurol. 157, 251-258.